Data At EULAR 2015 Showcase Commitment Of Janssen Pharmaceutical To Advancing Innovative Treatments For Immune And Inflammatory Diseases

BEERSE, Belgium--(BUSINESS WIRE)--The Janssen Pharmaceutical Companies* announced today that 17 Janssen Immunology abstracts in ankylosing spondylitis, rheumatoid arthritis, psoriatic arthritis and psoriasis, will be presented at the Annual European Congress of Rheumatology (EULAR), 10–13 June, in Rome, Italy.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC